Stryker Corporation (SYK) is scheduled to release first-quarter 2024 results on Apr 30, after market close. In the last reported quarter, the company delivered an earnings surprise of 5.81%.Q1 EstimatesThe Zacks Consensus Estimate for earnings is pegged at $2.35 per share, indicating an increase of 9.8% year over year.The consensus mark for revenues is pinned at $5.06 billion, implying growth of 5.8% from the prior-year quarter’s reported figure.Factors to NoteStryker's MedSurg and Neurotechnology segment w ...

The market expects Stryker (SYK) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on Ap ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Stryker (SYK) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.Stryker is one of 1062 companies in the Medical group. The Medical group currently sits at #5 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Ra ...

Stryker Corporation (SYK) recently announced that it has completed the acquisition of SERF SAS, a France-based joint replacement company from Menix.The acquisition of SERF SAS demonstrates Stryker’s commitment to orthopedic excellence and expands its worldwide range. Together with the SERF SAS team, Stryker aims to aid in advanced product innovation and customer satisfaction.Price PerformanceFor the past six months, SYK’s shares have rallied 23.0% compared with the industry’s rise of 10.0%. The S&P 500 incr ...

Stryker Corporation (SYK) is well poised for growth, backed by a robust robotic arm-assisted surgery platform, Mako, and a diversified product portfolio. Meanwhile, an improvement in price also buoys optimism.Shares of this Zacks Rank #2 (Buy) company have risen 17.9% year to date compared with the industry’s 4.1% growth. The S&P 500 Index has increased 8.3% in the same time frame.Stryker, with a market capitalization of $135.6 billion, is one of the world’s largest medical device companies operating in the ...

MAHWAH, N.J., USA, March 21, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a leading global medical technology company, announced today that it has completed the previously announced acquisition of SERF SAS, a France-based joint replacement company, from Menix. "The acquisition of SERF SAS further strengthens our global portfolio and reinforces our dedication to orthopaedic excellence," said Katherine Truppi, President of Stryker's Joint Replacement division. "We welcome the SERF SAS team to Stryker and look fo ...

Stryker Corporation (SYK) recently announced that the first shoulder arthroplasty surgery using Blueprint Mixed Reality (MR) Guidance has been completed in Europe.First shoulder arthroplasty surgery has been completed in Europe by Professor Julien Berhouet, MD, PhD, CHRU Tours Hospital, France, and Dr. Lionel Neyton, MD, orthopedic shoulder surgeon at Centre Orthopédique Santy and Hôpital Privé Jean Mermoz in Lyon, France.Price PerformanceFor the past six months, SYK’s shares have rallied 22.0% compared wit ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-13149 STRYKER CORPORATION (Exact name of registrant as specified in its charter) | Michigan | 38-1239739 | | --- | --- | | (State of incorporation) | (I.R.S. Employer Identifica ...

gorodenkoff/iStock via Getty Images Stryker (NYSE:SYK) is a leading medical technology company with a diversified product portfolio. Target markets include orthopedics, spine, surgical instruments, neurotechnology, and medical and surgical equipment. Stryker has a strong position within robotics for orthopedic surgery and is also demonstrating solid growth across its other businesses. While the company's valuation has risen substantially in recent years, this is in response to accelerating growth, impro ...

Portage, Michigan, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable April 30, 2024 to shareholders of record at the close of business on March 29, 2024, representing an increase of 6.7% versus the prior year and unchanged from the previous quarter.  About Stryker Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers inno ...